Drug Trial Radar · NCT05295459
Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)
Last checked: Nov 19, 2026Latest source record: Feb 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
182
Actual
Start
May 13, 2022
Primary completion
Apr 2, 2025
Study completion Apr 2, 2025
Sponsor
- Lead sponsor
- Lyra TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multicenter, phase III, randomized, blinded, controlled, parallel group.
Conditions
- Chronic Sinusitis
- Chronic Rhinosinusitis (Diagnosis)
Interventions
LYR-210Drug
LYR-210 drug matrix (mometasone furoate)
Sham procedure controlDrug
Sham procedure control
Background therapyOther
Daily Saline Irrigation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline (CFBL) in the 7-day Average Composite Score of 3 Cardinal Symptoms (3CS) in Participants Without Nasal PolypsTime frame: Week 24
Locations
57 sites in 6 countries. Site status is shown where the registry gives one.
Novak Clinical Trials
Tucson, Arizona
Keck School of Medicine at USC Medical Center
Arcadia, California
Sensa Health Clinical Research
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
University of California - Irvine Medical Center
Orange, California
Sacramento Ear Nose and Throat Surgical and Medical Group, Inc
Roseville, California
University of California - Davis
Sacramento, California
Regional Head & Neck Consulting - SENTA Clinic
San Diego, California
Breathe Clear Institute
Torrance, California
Colorado ENT and Allergy
Colorado Springs, Colorado
Ear, Nose and Throat Associates of South Florida, P.A.
Boynton Beach, Florida
ENT and Allergy Associates of Florida - Brandon
Brandon, Florida
ENT and Allergy Associates of Florida - Plantation - Dr. Johnson
Plantation, Florida
ENT and Allergy Associates of Florida - Plantation - Dr. Wright
Plantation, Florida
ENT and Allergy Associates of Florida
Port Saint Lucie, Florida
The University of Chicago Medical Center (UCMC)
Chicago, Illinois
Indiana University
Indianapolis, Indiana
University of Kansas Medical Center (KUMC)
Fairway, Kansas
Tandem Clinical Research
Marrero, Louisiana
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
University of Missouri-Columbia
Columbia, Missouri
St Louis University
St Louis, Missouri
ENT and Allergy Associates, LLP - Fifth Avenue New York
New York, New York
Columbia University
New York, New York
University of Rochester
Rochester, New York
ENT and Allergy Associates - White Plains
White Plains, New York
Carolina Ear, Nose, & Throat Clinic/CENTRI, Inc.
Orangeburg, South Carolina
Houston Methodist Hospital
Houston, Texas
ENT Associates of Texas
McKinney, Texas
Lyra Investigational Site
Ogden, Utah
Lyra Investigational Site
Richmond, Virginia
University Hospital Gent
Ghent, Belgium
Universitaire Ziekenhuizen Leuven
Leuven, Belgium
University Multiprofile Hospital for Active Treatment
Burgas, Bulgaria
UMHAT Kaspela Ltd
Plovdiv, Bulgaria
Military Medical Academy Multiprofile Hospital
Sofia, Bulgaria
Diagnostic and Consulting Center Mladost - Varna
Varna, Bulgaria
HNO Praxis Dr. Andrea Kienle-Gogolok
Baden, Germany
HNO Zentrum am Kudamm
Berlin, Germany
Universitaetsklinikum Carl Gustav Carus Dresden
Dresden, Germany
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.